Tisenc

About Tisenc

Tisenc is a pioneering company specializing in the development and production of advanced Chemiluminescence Immunoassay (CLIA) systems. The company serves the medical diagnostics market, providing high-sensitivity diagnostic tools that are crucial for accurate and rapid disease detection. Tisenc's core products include the ACCRE 6 and ACCRE 8 CLIA platforms, which offer pg-level detection sensitivity, 24-hour standby, and minimal maintenance requirements. These systems are designed to perform up to 36 tests per hour with a test time of 10-20 minutes, making them highly efficient for clinical settings.

Tisenc operates with a fully independent research and development (R&D) and production model, supported by a team of highly educated professionals, over 70% of whom hold master's degrees or higher. The company's facilities include R&D labs and GMP-certified factories, covering a total area of over 5000 square meters. This infrastructure enables Tisenc to maintain complete control over the quality and innovation of its products.

The business model of Tisenc revolves around selling its CLIA systems and related reagents to healthcare providers, laboratories, and research institutions. Revenue is generated through the sale of these diagnostic systems and the ongoing supply of reagents required for their operation. Tisenc's competitive edge lies in its high-quality, low-maintenance products that offer reliable and rapid diagnostic capabilities.